Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652818 · ClinicalTrials.gov registry record · Phase 2
Dental Pain Study of Analgesics in Patients Undergoing Molar Removal
A Phase 2 study, sponsored by Nevakar.
- Completed
- Registry status
- Phase 2
- Development phase
- 115
- Enrollment target
NCT03652818 is a Phase 2 study that has completed, run by Nevakar. The registered enrollment target is 115 participants.
The verdict
NCT03652818, a Phase 2 study, has completed, sponsored by Nevakar.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 115 participants
- Enrollment target
Study Summary
* Accessing the efficacy and safety of pregabalin when used alone and in combo with acetaminophen in a dental pain model. * To test whether pre-operative dose of pregabalin increases the time to significant post-operative pain (NRS ≥ 5), and hence time to first analgesia consumed post-operatively.
Interventions
- DRUG Pre-Op pregabalin
- DRUG Pre-Op Placebo 1
- DRUG Post-Op pregabalin
- DRUG Post-Op Placebo 1
- DRUG Post-Op Placebo 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2018-09-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652818
The ClinicalTrials.gov registry entry for NCT03652818 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevakar, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Pre-Op pregabalin is the first listed.
NCT03652818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03652818 about?
NCT03652818 is a clinical study titled "Dental Pain Study of Analgesics in Patients Undergoing Molar Removal". * Accessing the efficacy and safety of pregabalin when used alone and in combo with acetaminophen in a dental pain model. * To test whether pre-operative dose of pregabalin increases the time to significant post-operative pain (NRS ≥ 5), and hence time to first analgesia consumed post-operatively.
What is the current status of trial NCT03652818?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 2018-06-15. Estimated completion is 2018-09-20.
What interventions are being tested in trial NCT03652818?
The interventions under investigation include: Pre-Op pregabalin (DRUG), Pre-Op Placebo 1 (DRUG), Post-Op pregabalin (DRUG), Post-Op Placebo 1 (DRUG), Post-Op Placebo 2 (DRUG).
Who is sponsoring clinical trial NCT03652818?
This trial is sponsored by Nevakar, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.